Full blood count
Total white blood count 6.4 10*9/L [4.0 - 10.0]
Red blood cell count 7.07 10*12/L [4.5 - 5.5]
Above high reference limit
Haemoglobin concentration 174 g/L [130.0 - 170.0]
Above high reference limit
Haematocrit 0.492 [0.4 - 0.5]
Mean cell volume 70 fL [83.0 - 101.0]
Below low reference limit
Mean cell haemoglobin level 24.6 pg [27.0 - 32.0]
Below low reference limit
Platelet count - observation 280 10*9/L [150.0 - 410.0]
Neutrophil count 2.99 10*9/L [2.0 - 7.0]
Lymphocyte count 2.75 10*9/L [1.0 - 3.0]
Monocyte count - observation 0.51 10*9/L [0.2 - 1.0]
Eosinophil count - observation 0.12 10*9/L [0.02 - 0.5]
Basophil count 0.03 10*9/L [0.0 - 0.1]
Nucleated red blood cell count 0.00 10*9/L
Haemoglobin A1c level - IFCC standardised
Haemoglobin A1c level - IFCC standardised 80 mmol/mol
Results from large clinical trials suggest a target HbA1c
close to 53 mmol/mol is clinically valuable in people with
Type 1 and Type 2 diabetes under 75 years old
Glycaemic targets should take into account the individual's age,
clinical condition, and hypoglycaemia risk
Cholesterol
Serum cholesterol level 5.9 mmol/L [3.6 - 5.0]
Above high reference limit
Comment Lipid modification in NICE CG181 is based on CVD risk rather
than solely on cholesterol results. Statins are recommended for
patients with cardiovascular disease, and in those with CVD risk
> or = to 10% at 10 years. A reduction > 40% from baseline
non-HDL-cholesterol should be achieved.
HDLC
Serum HDL cholesterol level 0.87 mmol/L [> 1.0]
Below low reference limit
Serum cholesterol level 5.9 mmol/L [3.6 - 5.0]
Above high reference limit
Serum cholesterol/HDL ratio 6.8
Serum non high density lipoprotein cholesterol level 5.0 mmol/L
Comment Lipid modification in NICE CG181 is based on CVD risk rather
than solely on cholesterol results. Statins are recommended for
patients with cardiovascular disease, and in those with CVD risk
> or = to 10% at 10 years. A reduction > 40% from baseline
non-HDL-cholesterol should be achieved.
Serum C reactive protein level 2 mg/L [0.0 - 10.0]
Liver function tests
Serum bilirubin level Unable to provide result due to increased sample turbidity
Serum total protein level Unable to provide result due to increased sample turbidity
Serum albumin level Unable to provide result due to increased sample turbidity
Serum globulin level Not valid to calculate
Serum alkaline phosphatase level 63 u/L [38.0 - 126.0]
Serum alanine aminotransferase level 29 u/L [0.0 - 50.0]
Urea and electrolytes
Serum sodium level 140 mmol/L [133.0 - 146.0]
Serum potassium level 4.2 mmol/L [3.5 - 5.3]
Serum urea level 5.5 mmol/L [1.7 - 7.1]
Serum creatinine level 61 umol/L [59.0 - 104.0]
eGFR using creatinine (CKD-EPI) per 1.73 square metres > 90 mL/min/1.73m^2
NOTE: From 18th July eGFR will be calculated using a new formula (CKD-
EPI)
Serum ferritin level 32 ug/L [23.0 - 300.0]
Serum folate level
Serum vitamin B12 level 517 ng/L [130.0 - 1100.0]
Serum folate level 16.1 ug/L [2.7 - 15.0]
Above high reference limit
B12 interpretation
Less Than 100ng/L Low B12
100-129 ng/L Borderline B12, may be due to causes other th
an B12
deficiency
Greater Than 130 ng/L Normal
Serum TSH level 0.33 mu/L [0.35 - 3.5]
Below low reference limit
Bone profile
Serum calcium level 2.35 mmol/L
CCA
.
Serum inorganic phosphate level 0.63 mmol/L [0.8 - 1.5]
Below low reference limit
Serum alkaline phosphatase level 63 u/L [38.0 - 126.0]
Serum albumin level Unable to provide result due to increased sample turbidity
Serum testosterone level 19.5 nmol/L [6.7 - 25.6]
TEC
Reference Range only applies to samples taken near to 9am. There is n
o
accepted reference range for samples taken later in the day, but they
are
usually significantly lower.
New reference range as of 06.01.2017
I don't feel well at all all the time very tired cant sleep at night also difficult breathing